Overview & Future of Regenerative Medicine Market | Industry Analysis

Regenerative medicines are used to repair, replace, and regenerate tissues and organs affected by injury, disease, or the natural ageing process. These medicines restore the functionality of cells & tissues and are used in several degenerative disorders such as dermatology, neurodegenerative diseases, cardiovascular, and orthopaedic applications. Stem cells are capable of proliferation and differentiation, which increase their importance in this field. The global regenerative medicine market was valued at $5,444 million in 2016 and is estimated to reach $39,325 million by 2023, registering a CAGR of 32.2% from 2017 to 2023.

The major factors boosting the market growth include technological advancements in tissue and organ regeneration, increasing prevalence of chronic diseases and trauma emergencies, a prominent potential of nanotechnology, and the emergence of stem cell technology. Moreover, the utilization of nanomaterials in wound care, drug delivery, and immunomodulation has opened growth avenues for the regenerative medicine market.

However, stringent regulations, operational inefficiency, and the high cost of regenerative medicine treatment are the key factors affecting market growth. Furthermore, advancements in stem cell technology and achieving core competency in the emerging economies are expected to fuel the market growth. Developed nations have adopted technological advancements in tissue engineering and regenerative medicine sectors, which would aid the expansion of the global market.

The cell therapy segment accounted for a significant share of about three-fifths the overall regenerative medicine market in 2016 due to the widespread adoption of cell therapy for treatment of several diseases such as musculoskeletal, cardiovascular, oncology, wound healing, and others. Small molecules and biologics have emerged as the fastest growing segment during the forecast period as these biologics are classic active substances delivering a better overall economic return. These molecules have revolutionized the treatment of specific diseases such as musculoskeletal diseases, cancer, rheumatoid arthritis, and non-healing wounds.

Musculoskeletal and wound healing segment accounted for about three-fifths share of the application market in 2016. Cell therapies are used in the treatment of musculoskeletal diseases such as bone tissue replacement, cartilage, tendon, and ligament repair and replacement. In addition, osteoporosis is one of the most prevalent diseases that require tissue engineering therapies. More than 75 million people suffer from osteoporosis in Europe, the U.S., and Japan every year, which boosts the demand for regenerative medicines.



Reset Password